Petros Grivas: This is a product of teamwork for many years

Petros Grivas, Associate Professor at University of Washington, shared on X/Twitter:

“This is a product of teamwork for many years: investigator-initiated trial of nivolumab +/- lirilumab as neoadjuvant treatment in cisplatin-ineligible patients with MIBC! Vadim Koshkin was a fellow when we started!”